This special issue on 'Genetic Testing and Psychosocial Research' is appearing a little more than a decade after the first studies on psychosocial aspects of cancer genetic testing were published in the professional literature. The continuing excitement and the growing breadth and depth of this new field of study are reflected in the fact that the call for papers for the current special issue yielded more submissions (from nine countries) than any previous Psycho-Oncology special issue. As medicine (and especially oncology) becomes increasingly intertwined with genetic advances, and as the number of people undergoing genetic testing increases, it becomes all the more important that we understand the human factors influencing uptake of genetic tests, adherence to regimens of screening or surveillance recommended to mutation carriers and high-risk individuals, and issues of individual, family, and community impact of genetic technologies and genetic knowledge.Our special issue, like the field as a whole, has a preponderance of articles focusing on hereditary breast/ovarian cancer (HBOC). However, the papers in this issue report on genetic testing impact for a wide range of conditions from one of the earliest types of cancer genetic testing, p53 testing for members of Li-Fraumeni Syndrome families, to the first report of genetic testing for familial melanoma. Psychosocial aspects of both hereditary non-polyposis colon cancer (HNPCC) and familial adenomatous polyposis (FAP) are reported. Some articles focus on issues that have been of interest since the beginning of studies in this field, such as measurement of distress and cancer worry for those approaching and adapting to genetic testing disclosure. Several focus on the complex issues related to family communication of genetic information, evoking new dilemmas such as the transmission of such information within families after the tested family member had died. Others deal with emerging issues in counseling, such as the understanding of inconclusive test results showing an unclassified variant. Papers are also included that are related to optimizing the support of patients with specific interventions, potential or actual, which may reduce the emotional burdens of living with hereditary cancer risk in a genetic age.These papers reveal much of what we have learned and are learning about how cancer genetic testing changes the lives of those to whom it is provided. The strong hold of psychological factors on the actions of individuals in the face of scientific information provided through high-quality genetic counseling and testing remains striking. Despite being told by medical professionals of the importance of informing relatives about the presence of a deleterious familial cancer-predisposing mutation, it can take years before such information is conveyed by the tested individuals to some sisters, brothers, adult children, stepchildren, or parents due to psychological hesitancies that take precedence over motivations to altruistically inform [1,2]. Gender also impa...